Gujarat Themis Biosyn Limited
Gujarat Themis Biosyn Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: GUJTHEM and BSE: 506879 (ISIN INE942C01045).
It has a market capitalisation of ₹3,908 crore, a last close of ₹358.65 on 2026-10-19, a one-year return of -16.9%.
Valuation: a price-to-earnings ratio of 80.26x, a price-to-book ratio of 13.58x, a dividend yield of 0.2%.
Profitability: return on equity of 17.4%, return on capital employed of 18.5%, an operating margin of 47.4%.
Growth: sales growth of 3.6% a year over three years, net profit growth of -7.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.56x, promoter holding of 59.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 3,908 |
| Last close | ₹358.65 |
| P/E (TTM) | 80.26x |
| P/B | 13.58x |
| Dividend yield | 0.2% |
| ROE (FY) | 17.4% |
| ROCE (FY) | 18.5% |
| Operating margin (TTM) | 47.4% |
| Sales growth, 3-year CAGR | 3.6% |
| Profit growth, 3-year CAGR | -7.0% |
| Debt / equity | 0.56x |
| Promoter holding | 59.3% |
| 1-year return | -16.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means